Everything REMS Under The Sun: FDA Lays Out Ambitious PDUFA V Meeting Agenda

The struggles that industry and FDA face when trying to best standardize and evaluate REMS are illustrated by the dozens of topics jammed into the two-day meeting.

More from United States

More from North America